Tradestie Institutional Equity Comparison Engine

ABVC vs UHGWW โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ABVC Overall Edge

ABVC Captures Institutional Edge (2โ€“0 Pillars ยท 6โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ABVC BioPharma, Inc. Common Stock (ABVC) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, ABVC trades at N/M Forward P/E with 0.0% operating margin (+104.5% YoY revenue) versus UHGWW at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ABVC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against UHGWW sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ABVC N/M vs UHGWW N/M Fwd P/E
Growth & Margin Winner ABVC
Op Margin 0.0% vs N/A ยท YoY +104.5% vs N/A
Momentum & Technical Winner ABVC
1Y -68.2% vs -69.9% ยท 52W Pos 7% vs 7%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ABVC NASDAQ
ABVC BioPharma, Inc. Common Stock
Pharmaceutical Preparations
$0.87
-1.56% 1D
Market Cap $23.9M
1M Return -17.28%
1Y Return -68.15%
Forward P/E N/M
Unified AI Score
47.4 / 100 HOLD
Tech 43.0 Fund 50.0 Flow 50.0 Mom 60.0
UHGWW NASDAQ
United Homes Group, Inc. Warrant
Operative Builders
$0.23
+28.13% 1D
Market Cap N/A
1M Return +37.03%
1Y Return -69.87%
Forward P/E N/M
Unified AI Score
51.6 / 100 HOLD
Tech 60.0 Fund 54.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABVC -68.15% UHGWW -69.87% Spread: +196.28 pp (UHGWW Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ABVC TTM Op. Margin: 0.0% UHGWW TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABVC vs UHGWW. Trailing 12-month operating profitability (ABVC 0.0% vs UHGWW N/A) and valuation multiples (ABVC N/M vs UHGWW N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABVC (6) vs UHGWW (1)
Institutional Metric ABVC UHGWW Criterion Row Winner
Market Capitalization Scale $23.9M N/A Larger Scale ABVC
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +104.5% N/A Higher Growth ABVC
Operating Margin (TTM) Profitability 0.0% N/A Higher Margin ABVC
Net Profit Margin Profitability 0.0% N/A Higher Margin ABVC
Return on Equity (ROE) Capital Efficiency -52.7% N/A Higher ROE ABVC
52-Week Range Position Momentum 7% ($1โ€“$3) 7% ($0โ€“$2) Stronger Trend Tie
Beta / 30D Volatility Risk Regime 1.24ฮฒ ยท 44% Vol 1.85ฮฒ ยท 112% Vol Lower Realized Risk ABVC
Unified Institutional Score Composite Signal 47.4 / 100 (HOLD) 51.6 / 100 (HOLD) Higher Composite UHGWW

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABVC vs UHGWW Buy Guide
ABVC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ABVC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
UHGWW UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live UHGWW Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABVC nor UHGWW registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.